| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd97b3aa94ad52e534f72e6ba933cf87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a0486c0a2a0a523d9f5d3389f432bbe8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate |
2006-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97867b85f8774a62bf3e30e1c03b9ed6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1658f54b283696e0cac74eed3f6a0919 |
| publicationDate |
2007-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2007142433-A1 |
| titleOfInvention |
Angiogenesis-affecting compounds and methods of use thereof |
| abstract |
Angiogenesis may be affected by administering a compound to a group of cells, a tissue or an organism. Such affect may be to inhibit or stimulate angiogenesis. The compounds may be used to treat disease states related to insufficient or unregulated angiogenesis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103476402-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015072939-A1 |
| priorityDate |
2004-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |